Poster Abstract Session:
239. Diagnostics Mycobacteriology
Saturday, October 7, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Elevated Neutrophil-to-Lymphocyte Ratio is an Effective Prognosis Indicator In Extra-Pulmonary Tuberculosis
Houda Ben Ayed, MD; Makram Koubaa, MD; Fatma Smaoui, MD; Yosra Mejdoub, MD; Tarak Ben Jemaa, MD; Imed Maaloul, MD; Sourour Yaich, MD; Mondher Abed, Director; Jamel Dammak, MD; Chakib Marrakchi, MD; Mounir Ben Jemaa, MD
Does Disseminated Nontuberculous Mycobacterial Disease cause False-positive Determine TB-LAM Lateral Flow Assay Results?
Jeremy Nel, MBChB, FCP(SA), Cert ID(SA); Prudence Ive, MBBCh, FCP(SA), Cert ID(SA); Ribka Berhanu, MD; Ian Sanne, MBBCh, FCP(SA); David Spencer, MBChB, FCP(SA), Cert ID(SA); Christopher Lippincott, MD
  • LAM-NTM Poster .pdf (3.4 MB)
  • Evaluation of the High Indeterminate Rate of the QuantiFERON®-Tb Gold In-Tube Assay in a Children’s Hospital
    Michelle Sewnarine, MD; Sujatha Rajan, MD; Lisa Rosen, Senior Biostatistician/ScM; Lorry Rubin, MD, FIDSA
    Utilization and Performance of a Laboratory Developed Nucleic Acid Amplification Test for the Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in a Low Prevalence Area: A 14 Year Study.
    Sanchita Das, MD; Nirav Shah, MD, MPH; Lance Peterson, MD, FIDSA, FSHEA; Kathy Mangold, PhD; Richard Thomson Jr., PhD; Karen Kaul, MD, PhD
  • IDSA mod final.pdf (782.8 kB)
  • Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) for Diagnosis of Active Tuberculosis in HIV-Infected Adults: a Prospective Cohort Study
    Munjit Na Songkhla, MD; Hutsaya Tantipong, MD; Sasima Tongsai, Phd; Nasikarn Angkasekwinai, MD
    Improved Detection and Accuracy of Mycobacterium Species Identification from Paraffin Embedded Tissues of Patients by Using Multigene Targeted PCR and Sequencing
    Julu Bhatnagar, PhD; Marlene DeLeon-Carnes, BS; Demi Rabeneck, MS; Veronica Rowlett, PhD; Gillian Hale, MD, MPH; Roosecelis Martines, MD, PhD; Atis Muehlenbachs, MD, PhD; Joy Gary, DVM, PhD; Jana M. Ritter, DVM; Wun-Ju Shieh, MD, PhD; Sherif Zaki, MD, PhD
    Interferon gamma release assay performance in pediatric tuberculosis disease in California
    Alexander Kay, MD; Shamim Islam, MD, DTM&H; Kristen Wendorf, MD, MS; Janice Westenhouse, MPH; Pennan Barry, MD, MPH
    Diagnostic Usefulness of Bronchoalveolar Lavage Fluid Xpert MTB/RIF in Patients with Suspected Pauci-bacillary Pulmonary Tuberculosis
    Seung Hyun Lee, MD; Jeongmin Hong, MD; Byunghan Ryu, MD; Min Jae Kim, MD; Yong Pil Chong, MD, PhD; Sang-Oh Lee, MD, PhD; Sang-Ho Choi, MD, PhD; Yang Soo Kim, MD, PhD; Jun Hee Woo, MD, PhD; Sung-Han Kim, MD, PhD
    Season Is Associated with Interferon Gamma Measured in QuantiFERON Gold In-Tube Test
    Saroochi Agarwal, PhD, MSPH; Duc T. Nguyen, MD, PhD; Edward A. Graviss, PhD, MPH, FIDSA
    Safety & Benefits of Directly Observed Therapy with Rifapentine and Isoniazid for Latent Tuberculosis Infection – Less is More?
    Lawrence Ha, MD; Megan Lam, PharmD; Negin Niknam, MD; Rebecca Schwartz, PhD; Rehana Rasul, MA, MPH; Loyce Mol, PharmD; Suzan Chin, CPhT; Marcia Epstein, MD, FIDSA; David Hirschwerk, MD; Elizabeth Revere, MD; Lisa Hayes, MD
    Prevalence of Tuberculous Spondylodisciitis and Diagnostic Utility of Xpert MTB RIF
    Rajalakshmi Ananthanarayanan, MBBS, DNB; Ranjith Unnikrishnan, MS; Sherin Shyni, MBBS; Amarnath Purayyil, MBBS
    Prevalence of Gene Mutations profiles by GenoType MTBDRplus/sl to First Line Antituberculosis Drugs and Clinical Characteristics in Drug Resistant Tuberculosis Patients Referred to the National Institute of Respiratory Diseases in Mexico City.
    Jose Arturo Martinez-Orozco, MD; Blanca A. Nuñez-Luna, MD; Luis A. Narváez-Diaz, Microbiologist; Mariela Segura-Del Pilar, PHD; Mario Mujica-Sanchez, MIcrobiologist; Miguel Angel Salazar-Lezama, MD; Christian D. Mireles-Davalos, MIcrobiologist
  • poster TB ID week.pdf (574.9 kB)
  • Resistance of Mycobacterium and outcomes of pulmonary tuberculosis depending on VNTR-profile among different age groups of patients in Ukraine
    Olha S. Konstantynovska, M.D.; P.I. Poteiko, M.D.; M.M. Kochuieva, MD; I.I. Hrek, M.D.; A.V. Rohozhin, M.D.; Olexii S. Solodiankin, M.D.
  • Konstantynovska Olha.pdf (438.5 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.